The Directorate General of Health Services, under the Union health ministry, has revised patient treatment guidelines in an order dated May 27. The guidelines dropped recommendations of repurposed drugs such as hydroxychloroquine, ivermectin and favipiravir as treatment for mild to moderate Covid-19 patients